These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study. Gray TR; LaGasse LL; Smith LM; Derauf C; Grant P; Shah R; Arria AM; Della Grotta SA; Strauss A; Haning WF; Lester BM; Huestis MA Ther Drug Monit; 2009 Dec; 31(6):769-75. PubMed ID: 19935364 [TBL] [Abstract][Full Text] [Related]
25. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy. Wingert WE; Feldman MS; Kim MH; Noble L; Hand I; Yoon JJ J Forensic Sci; 1994 Jan; 39(1):150-8. PubMed ID: 8113697 [TBL] [Abstract][Full Text] [Related]
26. Nicotine and metabolites in paired umbilical cord tissue and meconium specimens. Marin SJ; Christensen RD; Baer VL; Clark CJ; McMillin GA Ther Drug Monit; 2011 Feb; 33(1):80-5. PubMed ID: 21192312 [TBL] [Abstract][Full Text] [Related]
27. Meconium for drug testing. Maynard EC; Amoruso LP; Oh W Am J Dis Child; 1991 Jun; 145(6):650-2. PubMed ID: 1817465 [TBL] [Abstract][Full Text] [Related]
28. Umbilical Cord Collection and Drug Testing to Estimate Prenatal Substance Exposure in Utah. Smid MC; Allshouse AA; McMillin GA; Nunez K; Cavin T; Worden J; Buchi K; Muniyappa B; Varner MW; Cochran G; Metz TD Obstet Gynecol; 2022 Aug; 140(2):153-162. PubMed ID: 35852263 [TBL] [Abstract][Full Text] [Related]
29. Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy. González-Colmenero E; Concheiro-Guisán A; Lorenzo-Martínez M; Concheiro M; Lendoiro E; de-Castro-Ríos A; Cañizo-Vázquez D; Martínez-Reglero C; Fernández-Lorenzo JR J Addict Dis; 2021; 39(2):175-182. PubMed ID: 33043834 [TBL] [Abstract][Full Text] [Related]
31. Quantification of 11-Carboxy-Delta-9-Tetrahydrocannabinol (THC-COOH) in Meconium Using Gas Chromatography/Mass Spectrometry (GC/MS). Peat J; Davis B; Frazee C; Garg U Methods Mol Biol; 2016; 1383():97-103. PubMed ID: 26660178 [TBL] [Abstract][Full Text] [Related]
32. Inflammation of the lungs, umbilical cord and placenta associated with meconium passage in utero. Review of 123 autopsied cases. Burgess AM; Hutchins GM Pathol Res Pract; 1996 Nov; 192(11):1121-8. PubMed ID: 9122031 [TBL] [Abstract][Full Text] [Related]
33. Opioid detection in maternal and neonatal hair and meconium: characterization of an at-risk population and implications to fetal toxicology. Moller M; Karaskov T; Koren G Ther Drug Monit; 2010 Jun; 32(3):318-23. PubMed ID: 20418801 [TBL] [Abstract][Full Text] [Related]
34. Patterns of Drugs and Drug Metabolites Observed in Meconium: What Do They Mean? McMillin GA; Wood KE; Strathmann FG; Krasowski MD Ther Drug Monit; 2015 Oct; 37(5):568-80. PubMed ID: 25565668 [TBL] [Abstract][Full Text] [Related]
35. Drugs of abuse testing in meconium. Gareri J; Klein J; Koren G Clin Chim Acta; 2006 Apr; 366(1-2):101-11. PubMed ID: 16413011 [TBL] [Abstract][Full Text] [Related]
36. High-sensitivity neonatal urine drug testing has similar positivity rates to meconium for detecting in utero exposure to methamphetamine and cocaine. Brown HM; Roper SM; Dietzen DJ; Crews BO J Anal Toxicol; 2024 Mar; 48(2):99-103. PubMed ID: 37952088 [TBL] [Abstract][Full Text] [Related]
37. Confirmation of cannabinoids in meconium using two-dimensional gas chromatography with mass spectrometry detection. Marin SJ; Coles R; Urry FM; McMillin GA J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):59-64. PubMed ID: 17881300 [TBL] [Abstract][Full Text] [Related]
38. Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids. Carlier J; La Maida N; Di Trana A; Huestis MA; Pichini S; Busardò FP Ther Drug Monit; 2020 Apr; 42(2):205-221. PubMed ID: 31809406 [TBL] [Abstract][Full Text] [Related]
39. Longitudinal trends in meconium drug detection in 46 US states between the years 2015 and 2020. Pandya V; Wilker C; Johnson-Davis KL J Anal Toxicol; 2023 Jul; 47(6):495-503. PubMed ID: 37079848 [TBL] [Abstract][Full Text] [Related]
40. Substance abuse in pregnant women: making improved detection a good clinical outcome. Araojo R; McCune S; Feibus K Clin Pharmacol Ther; 2008 Apr; 83(4):520-2. PubMed ID: 18349872 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]